Top

Published in:

01-07-2014 | Research

Fuzzy Clustering Analysis of Osteosarcoma Related Genes

Authors: Kai Chen, Dajiang Wu, Yushu Bai, Xiaodong Zhu, Ziqiang Chen, Chuanfeng Wang, Yingchuan Zhao, Ming Li

Published in: Pathology & Oncology Research | Issue 3/2014

Abstract

Osteosarcoma is the most common malignant bone-tumor with a peak manifestation during the second and third decade of life. In order to explore the influence of genetic factors on the mechanism of osteosarcoma by analyzing the inter relationship between osteosarcoma and its related genes, and then provide potential genetic references for the prevention, diagnosis and treatment of osteosarcoma, we collected osteosarcoma related gene sequences in Genebank of National Center for Biotechnology Information (NCBI) and local alignment analysis for a pair of sequences was carried out to identify the measurement association among related sequences. Then fuzzy clustering method was used for clustering analysis so as to contact the unknown genes through the consistent osteosarcoma related genes in one class. From the result of fuzzy clustering analysis, we could classify the osteosarcoma related genes into two groups and deduced that the genes clustered into one group had similar function. Based on this knowledge, we found more genes related to the pathogenesis of osteosarcoma and these genes could exert similar function as Runx2, a risk factor confirmed in osteosarcoma, this study may help better understand the genetic mechanism and provide new molecular markers and therapies for osteosarcoma.

Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790PubMedCrossRef

Fletcher C.D, Unni K.K, Mertens F (2002) Pathology & genetics: tumours of soft tissue and bone, World Health Organization

Levine AJ (1997) p53, the cellular gatekeeper review for growth and division. Cell 88:323–331PubMedCrossRef

Kansara M, Thomas DM (2007) Molecular pathogenesis of osteosarcoma. DNA Cell Biol 26:1–18PubMedCrossRef

Sjin RTT, Naspinski J, Birsner A, Li C, Chan R, Lo K, Gillies S, Zurakowski D, Folkman J, Samulski J (2006) Endostatin therapy reveals a U-shaped curve for antitumor activity. Cancer Gene Ther 13:619–627CrossRef

Mohammed RAA, Green A, El-Shikh S, Paish E, Ellis I, Martin S (2007) Prognostic significance of vascular endothelial cell growth factors-A,-C and-D in breast cancer and their relationship with angio-and lymphangiogenesis. Br J Cancer 96:1092–1100PubMedCentralPubMedCrossRef

IIDA K, NOBORI T, MATSUMINE A, ISAKA A, Seto M, Shiraishi T, Uchida A (2003) Effect of retinoblastoma tumor suppressor gene expression on chemosensitivity of human osteosarcoma cell lines. Oncol Rep 10:1961–1965PubMed

Ek ET, Dass CR, Contreras KG, Choong PF (2007) Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clinical Exp Metastasis 24:93–106CrossRef

Stricker S, Fundele R, Vortkamp A, Mundlos S (2002) Role of Runx genes in chondrocyte differentiation. Dev Biol 245:95–108PubMedCrossRef

10.

Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi J-Y, Komori T, Stein JL, Lian JB (2003) Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res 63:5357–5362PubMed

11.

Choi J-Y, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, Van Wijnen AJ, Lian JB (2001) Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci 98:8650–8655PubMedCentralPubMedCrossRef

12.

Ping G, Liangtian S, Shilun L, Lei S (1996) A theoretical study of the effect of porous media on the dew point pressure of a gas condensate, in, SPE Gas Technology Symposium

13.

Saeidi, L. Handy (1974) Flow and phase behavior of gas condensate and volatile oils in porous media, in, SPE California Regional Meeting

14.

Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680PubMedCentralPubMedCrossRef

15.

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410PubMedCrossRef

16.

Casey R (2005) Blast sequences aid in genomics and proteomics. Business Intelligence Network

17.

Gustafson DE, Kessel WC (1978) Fuzzy clustering with a fuzzy covariance matrix, in, Decision and Control including the 17th Symposium on Adaptive Processes, 1978 I.E. Conference on, IEEE, pp. 761–766

18.

Dembele D, Kastner P (2003) Fuzzy C-means method for clustering microarray data. Bioinformatics 19:973–980PubMedCrossRef

19.

Pickert L, Reuter I, Klawonn F, Wingender E (1998) Transcription regulatory region analysis using signal detection and fuzzy clustering. Bioinformatics 14:244–251PubMedCrossRef

20.

Bezdek JC (1981) Pattern recognition with fuzzy objective function algorithms, Kluwer Academic Publishers

21.

Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci 95:14863–14868PubMedCentralPubMedCrossRef

22.

Banerjee C, Javed A, Choi J-Y, Green J, Rosen V, Van Wijnen AJ, Stein JL, Lian JB, Stein GS (2001) Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142:4026–4039PubMedCrossRef

23.

Stein GS, Lian JB (1993) Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424–442PubMedCrossRef

24.

Stewart M, Terry A, Hu M, O’hara M, Blyth K, Baxter E, Cameron E, Onions D, Neil J (1997) Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci 94:8646–8651PubMedCentralPubMedCrossRef

25.

Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, Richards CD (2000) Murine oncostatin m stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 157:1187–1196PubMedCentralPubMedCrossRef

26.

Horn D, Fitzpatrick WC, Gompper PT, Ochs V, Bolton-Hansen M, Zarling J, Malik N, Todaro GJ, Linsley PS (1990) Regulation of cell growth by recombinant oncostatin M. Growth Factors 2:157–165PubMedCrossRef

27.

Grant SL, Begley CG (1999) The oncostatin M signalling pathway: reversing the neoplastic phenotype? Molecular Med Today 5:406–412CrossRef

28.

Klausen P, Pedersen L, Jurlander J, Baumann H (2000) Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene 19:3675PubMedCrossRef

29.

Halfter H, Lotfi R, Westermann R, Young P, Ringelstein EB, Stögbauer FT (1998) Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM). Growth Factors 15:135–147PubMedCrossRef

30.

Bellido T, Borba VZ, Roberson P, Manolagas SC (1997) Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138:3666–3676PubMed

31.

de Hooge AS, van de Loo FA, Bennink MB, de Jong DS, Arntz OJ, Lubberts E, Richards CD, van den Berg WB (2002) Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-κB ligand. Am J Pathol 160:1733–1743PubMedCentralPubMedCrossRef

32.

Liu F, Aubin J, Malaval L (2002) Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF. Bone 31:212PubMedCrossRef

33.

Wang Z-Q, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF (1992) Bone and haematopoietic defects in mice lacking c-fos

34.

Grigoriadis AE, Wang Z-Q, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443–448PubMedCrossRef

35.

Grigoriadis AE, Wang Z-Q, Wagner EF (1995) Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet 11:436–441PubMedCrossRef

36.

Chambers T, Fuller K (1985) Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 76:155–165PubMed

37.

Fuller K, Gallagher A, Chambers T (1991) Osteoclast resorption—stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix. Biochem Biophys Res Commun 181:67–73PubMedCrossRef

38.

Rozen N, Ish-Shalom S, Rachmiel A, Stein H, Lewinson D (2000) Interleukin-6 modulates trabecular and endochondral bone turnover in the nude mouse by stimulating osteoclast differentiation. Bone 26:469–474PubMedCrossRef

Title: Fuzzy Clustering Analysis of Osteosarcoma Related Genes
Authors: Kai Chen
Dajiang Wu
Yushu Bai
Xiaodong Zhu
Ziqiang Chen
Chuanfeng Wang
Yingchuan Zhao
Ming Li
Publication date: 01-07-2014
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 3/2014
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-013-9725-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Clinicopathological and Molecular Spectrum of Ewing Sarcomas/PNETs, Including Validation of EWSR1 Rearrangement by Conventional and Array FISH Technique in Certain Cases

Gastrointestinal Mucositis: The Role of MMP-Tight Junction Interactions in Tissue Injury

Possible Prognostic Value of BORIS Transcript Variants Ratio in Laryngeal Squamous Cell Carcinomas – a Pilot Study

Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma

Prognostic Value of Podoplanin Expression in Oral Squamous Cell Carcinoma―A Regression Model Auxiliary to UICC Classification

Characterization of the Attenuation of Breast Cancer Bone Metastasis in Mice by Zoledronic Acid Using 99mTc bone Scintigraphy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer